What You Should Know:
– Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Clinical Data Studio, a unified experience that…
Continue Reading
What You Should Know:
– Foresite Capital, a San Francisco, CA-based healthcare and life sciences investment firm, announced today the successful closing of its sixth fund with a significant $900M in capital commitments. This new…
Continue Reading
What You Should Know:
– Wheel, a leading provider of telehealth and virtual care solutions, announces the launch of its AI-driven Horizon™ platform.
– Horizon sets a new standard in care delivery by using AI to…
Continue Reading
What You Should Know:
– Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, proudly announces the successful completion of a $7.5 million Series A funding round. This funding, led by Genoa Ventures with participation…
Continue Reading
The world of healthcare is constantly growing and evolving. We are constantly coming up with new ideas and developing new technologies all in the spirit of making things better, not only for our own…
Continue Reading
What You Should Know:
– Verily, Alphabet’s precision health subsidiary, today announced Lightpath, a next-generation chronic care solution designed to address the evolving needs of health plans and their members.
– The initial offering, Lightpath Metabolic,…
Continue Reading
Every week, we shine a spotlight on one of our DigitalHealth.London companies, founders, or NHS fellows. Today we are excited to feature Karina Malhotra, who is currently participating in the DigitalHealth.London Leap programme.
[embedded content]Find…
What You Should Know:
– ALZpath, a leader in Alzheimer’s disease diagnostics, announced a licensing agreement with Roche for their innovative pTau217 antibody. This paves the way for a blood test to diagnose Alzheimer’s disease…
Continue Reading
What You Should Know:
– Helix, a leader in population genomics, is launching new datasets designed to empower life science companies in developing precision medicine therapies.
– These comprehensive datasets, built through collaborations with various health…
Continue Reading
What You Should Know
– Sware has secured $6 million in Series B funding to enhance its software validation solution for life sciences companies.
– The new funding will support research and development, AI-driven capabilities, and…
Continue Reading
